Lv3
300 积分 2024-03-05 加入
Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N-activating mutation
1个月前
已完结
Neonatal Neuroblastoma
1个月前
已完结
Advancing therapy for neuroblastoma
2个月前
已完结
Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study
2个月前
已完结
Drug Repositioning Using Computer-aided Drug Design (CADD)
3个月前
已完结
Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers
3个月前
已完结
The past, present, and future of ALK-targeted drug discovery
3个月前
已完结
Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets
3个月前
已完结
Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review
3个月前
已完结
ALK in cancer: from function to therapeutic targeting
3个月前
已完结
皖公网安备34019202002308
